Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2007
04/18/2007CN1948307A Preparation method of 5-(2-pyridyl)-2-sulfhydryl-1,3,4-thiadiazole
04/18/2007CN1948304A Heteraryl ring thiosemicarbazone kind compound and its derivative
04/18/2007CN1948289A Phenacyl-2,6-dimethyl pyridine-3,5-diethylketone hydrazone and its synthesis method
04/18/2007CN1948288A 4-hydroxy phenacyl-2,6-dimethyl pyridine-3,5-diethyl ketone hydrazone and its synthesis method
04/18/2007CN1948287A Acetyl-2,6-dimethyl pyridine-3,5-diethyl ketone hydrazone and its synthesis method
04/18/2007CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same
04/18/2007CN1311122C Method for delivering biologically active substances
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/18/2007CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same
04/18/2007CN1310892C Dithiocarbamate derivatives and their use as antibacterial agents
04/18/2007CN1310888C Method for producing 4-haloalkyl nicotinic acid amides
04/18/2007CN1310887C Method for producing 1,3-disubstituted 2-nitroguanidines
04/18/2007CN1310882C Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7205411 for treatment of neuropathic pain
04/17/2007US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes
04/17/2007US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders
04/17/2007US7205305 Inhibitors of p38
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205054 Metal coordination compound, luminescence device and display apparatus
04/17/2007CA2407759C Substituted phenylacetamides and their use as glucokinase activators
04/17/2007CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists
04/17/2007CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors
04/17/2007CA2273942C Process for the preparation of an organozinc reagent
04/17/2007CA2250586C Meta-substituted phenylene sulphonamide derivatives
04/17/2007CA2226082C Photochemically cross-linked polysaccharide derivatives having no photopolymerisable functional groups
04/17/2007CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids
04/17/2007CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/17/2007CA2187979C Process for preparing nicotinamide
04/17/2007CA2106882C Azaquinoxalines, processes for their preparation and their use
04/12/2007WO2007041379A1 Met kinase inhibitors
04/12/2007WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007WO2007041365A2 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007WO2007040289A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same
04/12/2007WO2007039736A1 Novel compounds
04/12/2007WO2007039555A1 Oxime ether compounds and their use as pesticides
04/12/2007WO2007039114A1 Novel nitrocatechol derivatives having selectin ligand activity
04/12/2007WO2007039112A1 Novel phloroglucinol derivatives having selectin ligand activity
04/12/2007WO2007039059A1 Novel carboxylic acid derivatives
04/12/2007WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
04/12/2007US20070083050 Intermediate compound which is used for the preparation of pioglitazone
04/12/2007US20070082907 Peroxisome proliferator activated receptor modulators
04/12/2007US20070082904 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes
04/12/2007US20070082883 HIV protease inhibitors
04/12/2007US20070082284 Metal complexes with bipodal ligands
04/12/2007CA2623686A1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007CA2622935A1 Novel nitrocatechol derivatives having selectin ligand activity
04/12/2007CA2622467A1 Novel phloroglucinol derivatives having selectin ligand activity
04/11/2007EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof
04/11/2007EP1772450A1 Method for producing 1,2-dihydropyridine-2-one compound
04/11/2007EP1771421A1 N-hydroxyamide derivatives and use thereof
04/11/2007EP1771420A1 Novel 2,6-diaminopyridine-3-one derivatives
04/11/2007EP1771419A1 Preparation of novel substituted haloarene compounds
04/11/2007EP1771418A2 Large conductance calcium-activated k channel opener
04/11/2007EP1440061B1 Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
04/11/2007EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives
04/11/2007EP1351938B1 Phenyl derivatives
04/11/2007EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/11/2007CN1946695A 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
04/11/2007CN1946694A 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides
04/11/2007CN1946693A Therapeutic formulations of desoxyepothilones
04/11/2007CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/11/2007CN1946670A Methods of preparing 1,3-enyne preparation using copper (I) catalysts
04/11/2007CN1944426A Pyridine derivative compound and its preparing method
04/11/2007CN1944409A Method for preparing haloxyfop-P-methyl with high optic purity
04/11/2007CN1944408A Process for preparing symmetric tetrachloro pyridine
04/11/2007CN1944406A Indole heterocyclic compounds and intermediate, and synthetic method
04/11/2007CN1943786A Ester compound and its medicinal application
04/11/2007CN1309720C Piperazine compounds
04/11/2007CN1309719C Derivative of phenylamide pyrimidine and application thereof
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/10/2007USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease
04/10/2007US7202381 Compounds as opioid receptor modulators
04/10/2007US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound
04/10/2007US7202365 Processes for the preparation of S-(-)-amlodipine
04/10/2007US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
04/10/2007US7202269 GlyT2 modulators
04/10/2007US7202260 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules
04/10/2007US7202244 Chk-1 inhibitors
04/10/2007US7202093 Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds
04/10/2007CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
04/10/2007CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2104148C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of n,n'-substituted ureas
04/05/2007WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/05/2007WO2007010463A3 2-amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives
04/05/2007WO2007002172A3 Hiv-1 protease inhibitors
04/05/2007WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
04/05/2007US20070078249 resultant polymers exhibit improved performance and processing properties; especially of ethylene alone or the copolymerisation of ethylene with higher 1-olefins to provide homopolymers and copolymers having controllable molecular weights
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078169 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
04/05/2007US20070078168 Pyridine carboxylic acid derivatives as glucokinase modulators
04/05/2007US20070078166 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone